<- Go Home

Outset Medical, Inc.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Market Cap

$48.3M

Volume

1.4M

Cash and Equivalents

$33.3M

EBITDA

-$123.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$35.5M

Profit Margin

30.97%

52 Week High

$5.22

52 Week Low

$0.44

Dividend

N/A

Price / Book Value

0.99

Price / Earnings

-0.33

Price / Tangible Book Value

0.99

Enterprise Value

$74.7M

Enterprise Value / EBITDA

-0.62

Operating Income

-$128.9M

Return on Equity

141.02%

Return on Assets

-26.83

Cash and Short Term Investments

$175.6M

Debt

$202.1M

Equity

$47.8M

Revenue

$114.7M

Unlevered FCF

-$63.8M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches